Loading clinical trials...
Loading clinical trials...
The primary objective of the study is to explore the efficacy and safety of ATryn® (antithrombin alfa) for the treatment of disseminated intravascular coagulation (DIC) associated with severe sepsis, ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
LEO Pharma
NCT07234630 · Hematologic Neoplasms, Solid Tumor Metastatic Cancer Advanced Cancer, and more
NCT03714048 · Death, Sudden, Cardiac, HEART ARREST, and more
NCT04873349 · Covid19, COVID-19 Respiratory Infection, and more
NCT04460664 · COVID, Disseminated Intravascular Coagulation, and more
NCT03577015 · Disseminated Intravascular Coagulation
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions